SIROLIMUS ELUTING STENT IS SUPERIOR TO PACLITAXEL ELUTING STENT IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY.
Soe Hee Ann, Ki‐Bae Seung, Kiyuk Chang(St. Mary's Hospital), Keon Yoong Moon, Yun Seok Choi(Inje University), Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital), Suk Min Seo(The Catholic University of Korea Incheon St. Mary's Hospital), Hun‐Jun Park(Soonchunhyang University), Soo Yeon Jung, Chan Joon Kim(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Tae‐Hoon Kim(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Chul Soo Park(The Catholic University of Korea Yeouido St. Mary's Hospital), Mahn Won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Wook Sung Chung(The Catholic University of Korea Seoul St. Mary's Hospital), Chan Seok Park(Catholic University of Korea)
Cited by 0
Related Papers
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304